Advertisement
Advertisement

ATOS

ATOS logo

Atossa Therapeutics Inc

0.9634
USD
-0.0166
-1.69%
Dec 20, 15:59 UTC -5
Closed
...

Atossa Therapeutics Inc Profile

About

Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA.

Info & Links

CEO

Steven C. Quay

Headquarters

107 SPRING STREET
SEATTLE, WA 98104, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.atossagenetics.com

Auditor

Ernst & Young LLP

Share holders

41

Employees

10

Atossa Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

121.20M

Enterprise Value

46.32M

Enterprise Value/EBITDA(ttm)

-1.57

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.67

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-35.74%

Return on Invested Capital(ttm)

-32.73%

Return on Assets(ttm)

-33.51%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-29.46M

Net Income Available to Common(ttm)

-26.91M

Diluted EPS(ttm)

-0.22

Share Statistics

Beta (5Y Monthly)

1.21

52-Week Change

31.07%

S&P 500 52-Week Change

24.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

125.80M

Dividend Yield

0.00%

Float4

116.24M

% Held by Insiders

7.60%

% Held by Institutions

12.74%

Balance Sheet

Total Cash(mrq)

74.88M

Total Cash Per Share(mrq)

0.60

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

13.30%

Quick Ratio(mrq)

13.30%

Book Value Per Share(mrq)

0.59

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.11

Free Cash Flow(ytd)

-14.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement